statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024

Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024 Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024 PR Newswire HOLON, Israel, July 23, 2024 HOLON...

Compugen to Present at Upcoming Antibody Industrial Symposium

Compugen to Present at Upcoming Antibody Industrial Symposium Compugen to Present at Upcoming Antibody Industrial Symposium PR Newswire HOLON, Israel, June 17, 2024 HOLON, Israel, June 17, 2024...

Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig

Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3 Trial Evaluating Rilvegostomig Compugen to Receive Milestone Payment Triggered by Dosing of First...

Compugen Reports First Quarter 2024 Results

Compugen Reports First Quarter 2024 Results Compugen Reports First Quarter 2024 Results PR Newswire HOLON, Israel, May 20, 2024 Enrollment completed and on track to present data from COM701 + COM902...

Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential

Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and...

Compugen Appoints David Silberman as Chief Financial Officer

Compugen Appoints David Silberman as Chief Financial Officer Compugen Appoints David Silberman as Chief Financial Officer PR Newswire HOLON, Israel, May 15, 2024 HOLON, Israel, May 15, 2024...

Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024

Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024 Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024 PR Newswire HOLON, ISRAEL, May 6, 2024 HOLON, ISRAEL, May...

Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024

Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024 Compugen to...

Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503

Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503 Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of...

Is Compugen Ltd. (NASDAQ:CGEN) Trading At A 36% Discount?

Key Insights Compugen's estimated fair value is US$3.61 based on 2 Stage Free Cash Flow to Equity Compugen's US$2.32...

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.

Volume	118,765.00
52-Wk High	$3.03
52-Wk Low	$0.53

CGEN Compugen Ltd

About

Feed

News

Sentiment

Earnings

Fundamentals